| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 603 |
| Total Income - EUR | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 603 |
| Total Expenses - EUR | - | 208 | 146 | 153 | 161 | 127 | 203 | 189 | 340 | 1.596 |
| Gross Profit/Loss - EUR | - | -208 | -146 | -153 | -161 | -127 | -203 | -189 | -340 | -993 |
| Net Profit/Loss - EUR | - | -208 | -146 | -153 | -161 | -127 | -203 | -189 | -340 | -993 |
| Employees | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Nelo Bio Sano Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 112 | 110 | 108 | 106 | 104 | 102 | 102 | 0 | 6.750 |
| Current Assets | - | 73 | 90 | 65 | 93 | 36 | 12.183 | 1.462 | 8.046 | 7.894 |
| Inventories | - | 42 | 42 | 41 | 40 | 39 | 38 | 39 | 0 | 7.097 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.809 | 0 |
| Cash | - | 31 | 49 | 24 | 52 | -3 | 12.145 | 1.423 | 1.236 | 797 |
| Shareholders Funds | - | -164 | -307 | -454 | -606 | -721 | -909 | -1.100 | -1.437 | -2.422 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 349 | 507 | 627 | 805 | 861 | 13.194 | 2.664 | 9.482 | 17.066 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4763 - 4763" | |||||||||
| CAEN Financial Year |
8730
|
|||||||||
Comments - Nelo Bio Sano Srl